Detalhe da pesquisa
1.
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma.
Blood
; 139(13): 1999-2010, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780623
2.
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Blood
; 139(8): 1177-1183, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797911
3.
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant.
Blood
; 139(11): 1670-1683, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871371
4.
Neoantigen Landscape Supports Feasibility of Personalized Cancer Vaccine for Follicular Lymphoma.
Blood Adv
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713894
5.
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia.
Sci Transl Med
; 14(633): eabm1375, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196021
6.
A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy.
Cancer Immunol Res
; 9(9): 1071-1087, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244297
7.
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies.
Clin Cancer Res
; 27(13): 3744-3756, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33986022
8.
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia.
Cancer Discov
; 10(12): 1854-1871, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32826231